A NEW FUNCTIONAL CYP3A4 POLYMORPHISM (CYP3A4*22) IS ASSOCIATED WITH INCREASED RISK OF DELAYED GRAFT FUNCTION AND WORSE RENAL FUNCTION IN CYCLOSPORIN-TREATED KIDNEY TRANSPLANT RECIPIENTS.

被引：0
|
作者：
Elens, L. [1 ]
Bouarmar, R. [2 ]
Hesselink, D. A. [3 ]
Haufroid, V. [4 ]
van Gelder, T.
van Schaik, R. H. [1 ,3 ]
机构：
[1] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands
[2] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands
[3] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[4] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [21] A Functional Polymorphism in the CYP3A4 Gene is Associated with Increased Risk of Coronary Heart Disease in the Chinese Han Population
    He, Bao-xia
    Shi, Lei
    Qiu, Jian
    Tao, Liang
    Li, Rui
    Yang, Liang
    Zhao, Shu-jin
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 108 (03) : 208 - 213
  • [22] The impact of CYP3A5*3 and CYP3A4*22 polymorphisms on Tacrolimus pharmacokinetics in a caucasian kidney transplant cohort
    Abdel-Kahaar, E.
    Winter, S.
    Schaeffeler, E.
    Olbricht, C.
    Shipkova, M.
    Schwab, M.
    Wieland, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S74 - S74
  • [23] Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients.
    Wang, Z.
    Han, Z.
    Tao, J.
    Chen, H.
    Sun, L.
    Tan, R.
    Gu, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 672 - 672
  • [24] Impact of CYP3A4*22 Allele on Sirolimus Dose Requirement in Kidney Transplant Patients
    Elens, L.
    Mourad, M.
    Delefortrie, Q.
    Mourad, G.
    De Meyer, M.
    Wallemacq, P.
    van Schaik, R. H.
    Haufroid, V.
    TRANSPLANTATION, 2012, 94 (10) : 575 - 575
  • [25] Pre-Transplant Pharmacogenetics Identifies CYP3A4 and CYP3A5 Heterogeneity among Caucasian Kidney Transplant Recipients
    Oliver, N.
    Lindberg, L.
    LeCorchick, S.
    Morris, D.
    Anand, S.
    Srinivas, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 571 - 571
  • [26] CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients
    Gijsen, Violette M. G. J.
    van Schaik, Ron H. N.
    Elens, Laure
    Soldin, Offie P.
    Soldin, Steven J.
    Koren, Gideon
    de Wildt, Saskia N.
    PHARMACOGENOMICS, 2013, 14 (09) : 1027 - 1036
  • [27] Association of CYP3A4*1B genotype with Cyclosporin A pharmacokinetics in renal transplant recipients: A meta-analysis
    Wang, Cai-e
    Lu, Ke-Peng
    Chang, Zhao
    Guo, Meng-Li
    Qiao, Hai-Ling
    GENE, 2018, 664 : 44 - 49
  • [28] The Genetic Polymorphism of CYP3A4 rs2242480 is Associated with Sirolimus Trough Concentrations among Adult Renal Transplant Recipients
    Lolita, Lolita
    Zheng, Ming
    Zhang, Xiang
    Han, Zhijian
    Tao, Jun
    Fei, Shuang
    Wang, Zijie
    Guo, Miao
    Yang, Haiwei
    Ju, Xiaobing
    Tan, Ruoyun
    Wei, Ji-Fu
    Gu, Min
    CURRENT DRUG METABOLISM, 2020, 21 (13) : 1052 - 1059
  • [29] Effect of Age and Allele Variants of CYP3A5, CYP3A4, and POR Genes on the Pharmacokinetics of Cyclosporin A in Pediatric Renal Transplant Recipients From Serbia
    Cvetkovic, Mirjana
    Zivkovic, Maja
    Bundalo, Maja
    Gojkovic, Ivana
    Spasojevic-Dimitrijeva, Brankica
    Stankovic, Aleksandra
    Kostic, Mirjana
    THERAPEUTIC DRUG MONITORING, 2017, 39 (06) : 589 - 595
  • [30] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09): : 659 - 665
12345